S
UTHR icon

Sachetta’s United Therapeutics UTHR Stock Holding History

Sachetta’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5K Buy
36
+22
+157% +$12.4K 0.01% 301
2026
Q1 		$8.3K Hold
14
– – ﹤0.01% 494
2025
Q4 		$6.82K Hold
14
– – ﹤0.01% 473
2025
Q3 		$5.87K Hold
14
– – ﹤0.01% 561
2025
Q2 		$4.02K Buy
14
+2
+17% +$598 ﹤0.01% 638
2025
Q1 		$3.7K Hold
12
– – ﹤0.01% 632
2024
Q4 		$4.24K Hold
12
– – ﹤0.01% 627
2024
Q3 		$4.3K Sell
12
-6
-33% -$2.03K ﹤0.01% 665
2024
Q2 		$6.2K Buy
18
+1
+6% +$265 ﹤0.01% 547
2024
Q1 		$3.74K Hold
17
– – ﹤0.01% 576
2023
Q4 		$3.74K Buy
+17
New +$3.92K ﹤0.01% 576

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Sachetta's UTHR Position: Q2 2026 in Review

Sachetta increased its United Therapeutics (UTHR) stake by 157% in Q2 2026, buying an estimated $12.4K and bringing the position to 36 shares worth $19.5K. The position accounts for 0.01% of the portfolio, ranked #301.

Sachetta first reported a position in UTHR in Q4 2023 and has held it in 11 quarters since. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Sachetta held 36 shares of United Therapeutics worth $19.5K as of Q2 2026.
  • Sachetta bought 22 United Therapeutics shares in Q2 2026, an estimated $12.4K.
  • United Therapeutics made up 0.01% of Sachetta's portfolio in Q2 2026, its #301 holding.
  • Sachetta first reported a position in United Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.